Promising schizophrenia drug tested in teens for first time
NCT ID NCT04779177
First seen Nov 12, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looked at how safe and how well the body handles a drug called lumateperone in teenagers aged 13 to 17 with schizophrenia or schizoaffective disorder. 26 teens took the drug by mouth, and researchers measured its levels in the blood and checked for side effects. The goal was to gather early information on dosing and safety for this age group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site
Hollywood, Florida, 33024, United States
-
Clinical Site
Atlanta, Georgia, 30331, United States
-
Clinical Site
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.